Position in CTMX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,942
-$336 QoQ
Shares Held
518
-58.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#167
of 178 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. CTMX ranks #219 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,455 | $28,042,892 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,412 | $12,104,158 | |
| 3 | TECH |
BIO-TECHNE Corp
|
68,452 | $4,836,133 | |
| 4 | INCY |
Incyte Corp
|
26,479 | $3,001,659 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,139 | $2,751,113 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
48,369 | $2,275,277 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
6,111 | $2,045,901 | |
| 8 | EXEL |
Exelixis, Inc.
|
36,758 | $2,000,002 |
All Filings in CTMX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,942 | 518 | Shares | Sole | 2026-08-10 | |
| 2022-06-30 | $2,278 | 1,245 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $3,324 | 1,245 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $5,390 | 1,245 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $6,337 | 1,245 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $7,880 | 1,245 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $9,623 | 1,245 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $8,154 | 1,245 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $4,621 | 695 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $5,789 | 695 | Shares | Sole | 2020-07-27 | |
| No filing history on record for this holder in this stock. | ||||||